Remove tag start-ups
article thumbnail

Grand Rounds November 18, 2022: The FIRST-ABC Pragmatic Trials of Non-Invasive Respiratory Support In Children (Padmanabhan Ramnarayan, MBBS, MD, FRCPCH, FFICM)

Rethinking Clinical Trials

Sick children, when they are acutely ill, start with standard oxygen therapy, which escalates to noninvasive respiratory support (CPAP/BIPAP or high flow nasal cannula) before invasive ventilation support in the ICU. What we found from the pilot RCT, was that there were two distinct populations, step-up (i.e., Key Points.

Trials 130
article thumbnail

Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA

pharmaphorum

Biogen and Eisai head towards the end of the year with some much-needed good news in their Alzheimer’s programmes, as the FDA awards a fast-track designation to lecanemab, their follow-up to recently approved Aduhelm.

Drugs 109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA)

Rethinking Clinical Trials

In 2021, DIHI started a Health AI Partnership to empower healthcare professionals to use AI effectively, safely, and equitably through community-informed up-to-date standards. The Health AI Partnership started with 7 organization partners and has expanded to about 20 organizations.

article thumbnail

Grand Rounds February 9, 2024: Pragmatic Recruitment of Underrepresented Groups – Experience From the Diuretic Comparison Project (Cynthia Hau, MPH)

Rethinking Clinical Trials

DCP started to understand if chlorthalidone would be more effective at preventing cardiovascular (CV) outcomes compared to hydrochlorothiazide for thiazide-type diuretic. DCP planned to launch 5 sites in the first year starting with the Boston Healthcare System. How long did the start up for the trial take?

article thumbnail

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

The intervention group started the program now. The control group started in 6 months and received a brochure that lists addresses of area food banks. The treatment group started with a mean 10.3 We see people visiting the fresh food pharmacies for up to 12 months. Randomization was stratified by HbA1c greater than 9.5

article thumbnail

Grand Rounds August 4, 2023: AI & ML: Want to Play a Game? (Eric Perakslis, PhD)

Rethinking Clinical Trials

For example, if the method of patient reported outcomes is gamified, patients will be more likely to continue reporting their outcomes on a regular basis rather than giving up or forgetting after the first time, which may increase the quality and quantity of data for the trial overall. This can be useful in the context of clinical trials.

article thumbnail

Axsome bounces back as FDA clears depression drug

pharmaphorum

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. Auvelity is the first drug Axsome has taken through to regulatory approval, but could be the first of a string of new products for the company, according to Tabuteau.

Drugs 98